Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00412620
Show Display Options
Rank Status Study
1 Terminated An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of Schizophrenia
Condition: Schizophrenia
Interventions: Drug: ABT-925;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.